SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xenova (XNVA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject5/8/2003 5:54:40 AM
From: nigel bates   of 173
 
And some comment...

Xenova drops on cancer drug, cash worries

LONDON, May 8 (Reuters) - Shares in Xenova Group Plc (LSE: XEN.L - news) fell 10 percent on Thursday as the British biotech firm failed to give a hoped-for update on its lead drug candidate and highlighted a tight cash position in its first-quarter results.

Xenova suffered a setback in February when patient enrolment into final stage clinical trials of experimental cancer drug tariquidar was temporarily suspended due to safety concerns, pending a report by an independent panel in May or June.

Some investors had hoped for news alongside the quarterly results but Chief Executive David Oxlade said Xenova was still awaiting the report from the Data Safety Monitoring Committee.

Xenova unveiled a quarterly loss of 3.29 million pounds against 3.25 million a year earlier, leaving it with cash reserves of 12.9 million pounds.

The company said it had "a reasonable degree of confidence" it could secure adequate funding to continue as a going concern but added it would cut costs if funds were not available in order to conserve cash resources.

"They are definitively starting to run relatively short of cash," said Sally Bennett, biotech analyst at ING.

The stock, which had run up ahead of the results, was two pence lower at 17p by 0825 GMT from a 52-week high of 62-3/4p.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext